Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/24682
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKalantaridou, S. N.en
dc.contributor.authorCalis, K. A.en
dc.contributor.authorVanderhoof, V. H.en
dc.contributor.authorBakalov, V. K.en
dc.contributor.authorCorrigan, E. C.en
dc.contributor.authorTroendle, J. F.en
dc.contributor.authorNelson, L. M.en
dc.date.accessioned2015-11-24T19:42:43Z-
dc.date.available2015-11-24T19:42:43Z-
dc.identifier.issn1556-5653-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/24682-
dc.rightsDefault Licence-
dc.subjectChromosomes, Human, X/*geneticsen
dc.subjectCross-Sectional Studiesen
dc.subjectFemaleen
dc.subjectGonadal Dysgenesis, Mixed/*genetics/*metabolismen
dc.subjectHumansen
dc.subjectPrimary Ovarian Insufficiency/*genetics/*metabolismen
dc.subjectTestosterone/*blood/*deficiency/geneticsen
dc.titleTestosterone deficiency in young women with 46,XX spontaneous premature ovarian failureen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1016/j.fertnstert.2006.04.028-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/17070197-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0015028206015068/1-s2.0-S0015028206015068-main.pdf?_tid=3894804976589310e4eb1b1bfff0f6f4&acdnat=1333463389_b66acc0e83936ed03ddab1391866d50e-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2006-
heal.abstractOBJECTIVE: To determine whether women with 46,XX spontaneous premature ovarian failure have lower serum free-T levels than do control women. DESIGN: Cross-sectional. SETTING: National Institutes of Health Clinical Research Center. PATIENT(S): Women with 46,XX spontaneous premature ovarian failure (n = 130). INTERVENTION(S): Evaluation while off any estrogen therapy and then again after receiving a standardized hormone regimen. Regularly menstruating control women (n = 65) were sampled during the midfollicular phase. MAIN OUTCOME MEASURE(S): Serum total T by RIA after extraction and column chromatography, free T by equilibrium dialysis, and sex hormone-binding globulin by immunoradiometric assay. RESULT(S): While off estrogen therapy patients had a median serum free-T concentration that was statistically significantly lower than controls (2.2 vs. 3.3 pg/mL). This dropped significantly lower to 1.9 pg/mL while the patients were on physiologic transdermal E(2) therapy. This is despite the fact that sex hormone-binding globulin levels did not change. While on E(2) therapy, 13% of women (95% confidence interval, 7.9%-20.3%) had serum free-T levels below the lower limit of normal (<1.1 pg/mL). CONCLUSION(S): As a group, young women with 46,XX spontaneous premature ovarian failure have reduced circulating free-T levels, both during an interval off of estrogen therapy and while on physiologic transdermal E(2) therapy.en
heal.journalNameFertil Sterilen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Kalantaridou-2006-Testosterone deficie.pdf194.12 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons